Claims for Patent: 5,616,491
✉ Email this page to a colleague
Summary for Patent: 5,616,491
Title: | Knockout mice |
Abstract: | Mice lacking expression of CD28 or particular CD45 isoforms in certain cells of the immune system are provided. Also provided are methods of using these mice. |
Inventor(s): | Mak; Tak W. (Toronto, CA), Thompson; Craig B. (Chicago, IL) |
Assignee: | Ontario Cancer Institute (Toronto, CA) Thompson; Craig B. (Chicago, IL) |
Application Number: | 08/528,363 |
Patent Claims: | 1. A DNA construct comprising intron 1 and exon 2 of a mouse CD28 gene into which a marker sequence has been inserted.
2. The DNA construct of claim 1 wherein said marker sequence comprising a neogene operably linked to a thymidine kinase promoter is substituted for the region between the XbaI site in intron 1 and the EcoRI site in exon 2 of the CD28 gene. 3. A mouse D3 embryonic stem cell line comprising the DNA construct of claim 2 and having the ATCC accession number CRL11382. |
Details for Patent 5,616,491
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2039-02-26 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2039-02-26 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2039-02-26 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.